Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
- PMID: 32698396
- PMCID: PMC7409323
- DOI: 10.3390/cancers12071974
Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
Abstract
Allogeneic (allo) hematopoietic cell transplantation (HCT) is the only curative treatment option for patients suffering from chemotherapy-refractory or relapsed hematological malignancies. The occurrence of morbidity and mortality after allo-HCT is still high. This is partly correlated with the immunological recovery of the T cell subsets, of which the dynamics and relations to complications are still poorly understood. Detailed information on T cell subset recovery is crucial to provide tools for better prediction and modulation of adverse events. Here, we review the current knowledge regarding CD4+ and CD8+ T cells, γδ T cells, iNKT cells, Treg cells, MAIT cells and naive and memory T cell reconstitution, as well as their relations to outcome, considering different cell sources and immunosuppressive therapies. We conclude that the T cell subsets reconstitute in different ways and are associated with distinct adverse and beneficial events; however, adequate reconstitution of all the subsets is associated with better overall survival. Although the exact mechanisms involved in the reconstitution of each T cell subset and their associations with allo-HCT outcome need to be further elucidated, the data and suggestions presented here point towards the development of individualized approaches to improve their reconstitution. This includes the modulation of immunotherapeutic interventions based on more detailed immune monitoring, aiming to improve overall survival changes.
Keywords: T cell subsets; allogeneic hematopoietic cell transplantation; biomarkers; conditioning; hematological malignancies; immune reconstitution; immunosuppressive therapies; serotherapy.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Bartelink I.H., Belitser S.V., Knibbe C.A.J., Danhof M., de Pagter A.J., Egberts T.C.G., Boelens J.J. Immune Reconstitution Kinetics as an Early Predictor for Mortality using Various Hematopoietic Stem Cell Sources in Children. Biol. Blood Marrow Transpl. 2013;19:305–313. doi: 10.1016/j.bbmt.2012.10.010. - DOI - PubMed
-
- Fedele R., Martino M., Garreffa C., Messina G., Console G., Princi D., Dattola A., Moscato T., Massara E., Spiniello E., et al. The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantation. Blood Transfus. 2012;10:174–180. - PMC - PubMed
-
- Komanduri K.V., St. John L.S., De Lima M., McMannis J., Rosinski S., McNiece I., Bryan S.G., Kaur I., Martin S., Wieder E.D., et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood. 2007;110:4543–4551. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
